Home

Anti-Aging

Navigation

Bladder Cancer
Breast Cancer
Cancer Drugs
Cancer Research
Cervical Cancer
Colon Cancer
Lung Cancer
Ovarian Cancer
Prostrate Cancer
Skin Cancer
Thyroid Cancer

Anti-Aging » Anti-Aging and Medical Conditions » Cancer » Lung Cancer » FDA Approves New Drug for the Most Common Type of Lung Cancer

The Food and Drug Administration (FDA) announced the approval of Tarceva (erlotinib) tablets as a single agent treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC), the ...

Original Article: FDA Approves New Drug for the Most Common Type of Lung Cancer

Continue Reading: 1 2 3 4 5

Email This Article

Post Your Comment

Print This Article

Peer Rating System: Would you recommend this article?
No I wouldn't 1 2 3 4 5 Yes I Would
0.00 out of 5, With 0 Votes

Category Articles

Eli Lilly Pays Monsanto $300 Million for Controversial Dairy Hor
Cholesterol Pill Taken by Thousands Causes Cancer
Extraordinary Creative and Psychic Powers of Animals
World Water Crisis Underlies World Food Crisis
Exercise and Limited TV Time Keeps Kids Trim
Hospital Deaths Go Public
Half of All Food Produced Worldwide is Wasted
FDA Allows Irradiation of Produce
Researchers Question Whether HPV Vaccine is Worth the Risk
Text-Messaging Injuries Caused by Distraction

Nav: [ 1 2 3 4 5 >> ]

Site Tree | Disclaimer
Link Index | Resources | More Resources

What is Anti-Aging, Anti-Ageing or Antiaging?

Home

Anti-Aging

Anti-Aging Information Partners

Anti-Aging Conferences

Anti-Aging Books

Anti-Aging Extras

Syndicate

Tools

No I wouldn't 1 2 3 4 5 Yes I Would

What is Anti-Aging, Anti-Ageing or Antiaging?

We are not affiliated with the American Academy for Anti-Aging Medicine (A4M)